Steady‐state pharmacokinetics and bioavailability of immediate‐release and extended‐release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1101-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate‐release and hydrophilic matrix extended‐release tablets in healthy Japanese subjects without co‐administration of an opioid antagonist

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 975-984

John Wiley & Sons Inc

Access to resources Recommend Favorite

USL255 extended‐release topiramate: Dose‐proportional pharmacokinetics and tolerability in healthy volunteers

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1069-1076

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of the pharmacokinetics of two different formulations of extended-release niacin

By Lauring B.   Rosko K.   Luo W.-L.   Wenning L.   Kissling J.   Roupe K.   Paolini J. F.   Wagner J.   Lai E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 995-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite